Meningococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Meningococcal Vaccine Trends and Forecast

The future of the global meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets. The global meningococcal vaccine market is expected to reach an estimated $6.66 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

A more than 150-page report is developed to help in your business decisions.

Meningococcal Vaccine by Segment

The study includes a forecast for the global meningococcal vaccine by type, end use, and region.

Meningococcal Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Polysaccharide
• Conjugate Vaccines
• Combination Vaccines
• Men B Vaccines
• Others

Meningococcal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Retail Pharmacies
• Hospital Pharmacies
• Others

Meningococcal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Meningococcal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies meningococcal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the meningococcal vaccine companies profiled in this report include-

• Merck
• Baxter International
• JN International Medical
• Biomed
• Pfizer
• GlaxoSmithKline
• Serum Institute India

Meningococcal Vaccine Market Insights

Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Within this market, hospital pharmacy will remain the largest segment due to the high volume of vaccinations administered in this facility.

Features of the Global Meningococcal Vaccine Market

Market Size Estimates: Meningococcal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Meningococcal vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Meningococcal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the meningococcal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the meningococcal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the meningococcal vaccine market size?

Answer: The global meningococcal vaccine market is expected to reach an estimated 6.66 billion by 2030.

Q.2 What is the growth forecast for meningococcal vaccine market?

Answer: The global meningococcal vaccine market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the meningococcal vaccine market?

Answer: The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

Q4. What are the major segments for meningococcal vaccine market?

Answer: The future of the meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets.

Q5. Who are the key meningococcal vaccine market companies?

Answer: Some of the key meningococcal vaccine companies are as follows:

• Merck
• Baxter International
• JN International Medical
• Biomed
• Pfizer
• GlaxoSmithKline
• Serum Institute India

Q6. Which meningococcal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Q7. In meningococcal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of meningococcal disease among adolescents and young adults in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the meningococcal vaccine market by type (polysaccharide, conjugate vaccines, combination vaccines, men B vaccines, and others), end use (retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?